Citation Impact
Citing Papers
Caenorhabditis elegans ADAR editing and the ERI-6/7/MOV10 RNAi pathway silence endogenous viral elements and LTR retrotransposons
2020 StandoutNobel
Consensus Statement of the Movement Disorder Society on Tremor
2008 Standout
Sublingual apomorphine (APL‐130277) for the acute conversion of OFF to ON in Parkinson's disease
2016
Determinants of disease and disability in the elderly: The Rotterdam elderly study
1991
The role of liquid–liquid phase separation in aggregation of the TDP-43 low-complexity domain
2019 Standout
Glutamate receptor ion channels
2005 Standout
Inflammation and Alzheimer's disease
2000 Standout
Non-motor symptoms of Parkinson's disease: diagnosis and management
2006 Standout
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
2010 Standout
Parkinson disease
2017 Standout
Evidence‐based medical review update: Pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004
2005
Laparoscopic Roux-en-Y Gastric Bypass for Morbid Obesity
2000
Parkinson's disease
2021 Standout
The central role of the prefrontal cortex in directing attention to novel events
2000
Novel Oral Drug Formulations
1994
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43)
1994 Standout
Somatic APP gene recombination in Alzheimer’s disease and normal neurons
2018 Nature
Disruption of attention to novel events after frontal lobe injury in humans
2000
Toward a model of eye movement control in reading.
1998 Standout
Opportunities and Challenges in International Collaborative Epidemiologic Research of Dementia and Its Subtypes: Studies Between Japan and the U.S.
1994
Traumatic brain injury and Alzheimer's disease: a review
2007
Updating P300: An integrative theory of P3a and P3b
2007 Standout
Alzheimer's disease
2011 Standout
The Reversible Dementias: Do They Reverse?
1988
Parkinson's disease: clinical features and diagnosis
2008 Standout
Shared decision-making in the medical encounter: What does it mean? (or it takes at least two to tango)
1997 Standout
Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
2021 Standout
The amyloid beta-protein of Alzheimer's disease is chemotactic for mononuclear phagocytes
1992
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
1990 Standout
Leisure Activities and the Risk of Dementia in the Elderly
2003 Standout
Control of goal-directed and stimulus-driven attention in the brain
2002 Standout
Parkinson's disease
2009 Standout
Frequency of levodopa‐related dyskinesias and motor fluctuations as estimated from the cumulative literature
2001
Development of dementing illnesses in an 80‐year‐old volunteer cohort
1989
The Reorienting System of the Human Brain: From Environment to Theory of Mind
2008 Standout
Immune attack: the role of inflammation in Alzheimer disease
2015 Standout
NMR studies in aqueous solution fail to identify significant conformational differences between the monomeric forms of two Alzheimer peptides with widely different plaque‐competence, Aβ(1–40)ox and Aβ(1–42)ox
2001 StandoutNobel
Efficacy of a support group programme for care-givers of demented patients in the community: a randomized controlled trial
1994
Parkinson's disease
2015 Standout
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
Neurovascular regulation in the normal brain and in Alzheimer's disease
2004 Standout
Increased risk of dementia following mild head injury for carriers but not for non-carriers of the APOE e4 allele
2006
TDP-43 Proteinopathy and Motor Neuron Disease in Chronic Traumatic Encephalopathy
2010
Apomorphine sublingual film for off episodes in Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 study
2019
Eye movements in reading and information processing: 20 years of research.
1998 Standout
Polymorphisms in the Sclerosteosis/van Buchem Disease Gene (SOST) Region Are Associated with Bone-Mineral Density in Elderly Whites
2004 StandoutNobel
Treatment interventions for Parkinson's disease: an evidence based assessment
2002
Elevated 4-Hydroxynonenal in Ventricular Fluid in Alzheimer’s Disease
1997
Designing hydrogels for controlled drug delivery
2016 Standout
Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial
2013
Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment
1991 Standout
Carotid-Artery Intima and Media Thickness as a Risk Factor for Myocardial Infarction and Stroke in Older Adults
1999 Standout
Non-motor features of Parkinson disease
2017 Standout
Visual symptoms in Parkinson's disease and Parkinson's disease dementia
2011
Medical Management of Levodopa-Associated Motor Complications in Patients with Parkinson???s Disease
2007
Rapid Communication: Characterization of β‐Amyloid Peptide from Human Cerebrospinal Fluid
1993
Systematic review of levodopa dose equivalency reporting in Parkinson's disease
2010 Standout
Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease
1996 Standout
Long-term neurologic outcome in psychogenic water drinkers with severe symptomatic hyponatremia: The effect of rapid correction
1990
Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein
1989 Standout
Oculomotor function in frontotemporal lobar degeneration, related disorders and Alzheimer's disease
2008
Genetic susceptibility and head injury as risk factors for Alzheimer's disease among community‐dwelling elderly persons and their first‐degree relatives
1993
Delirium in Older Persons
2006 Standout
Hyponatremia
2000 Standout
Criteria for the diagnosis of corticobasal degeneration
2013 Standout
Alzheimer's Disease
1986
Management of Parkinson's disease: An evidence-based review
2002
Head injury and the risk of AD in the MIRAGE study
2000
Covert Attention and Eye Movements during Reading
1989
Osmotic Demyelination Syndrome Following Correction of Hyponatremia
1986 Standout
Diagnosis and Treatment of Parkinson Disease
2020 Standout
Hemiparesis apparently due to central pontine myelinolysis following hyponatremia
1983
Reinnervation of the hippocampal perforant pathway zone in Alzheimer's disease
1987
Practice parameter: Management of dementia (an evidence-based review) [RETIRED]
2001 Standout
Hydrogel bioelectronics
2018 Standout
Visual Symptoms in Parkinson's Disease
2011
Retinopathy in Parkinson disease
2009
Repetitive Mild Brain Trauma Accelerates Aβ Deposition, Lipid Peroxidation, and Cognitive Impairment in a Transgenic Mouse Model of Alzheimer Amyloidosis
2002
A case‐control study of Alzheimer's disease in China
1992
Subcortical functions in language: A working model
1985
A faulty negative feedback control underlies the schizophrenic syndrome?
1991 StandoutNobel
Role of dopamine agonists in Parkinson’s disease: an update
2007
Meta-Analysis: Surgical Treatment of Obesity
2005 Standout
Diabetes mellitus and the risk of dementia
1999 Standout
Epidemiology of clinically diagnosed Alzheimer's disease
1986
RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
1996 StandoutNature
Unilateral thalamic deep brain stimulation for refractory essential tremor and Parkinson's disease tremor
1998
Attentional and Oculomotor Influences on Visual Field Anisotropies in Visual Search Performance
1996
Free Radicals in the Physiological Control of Cell Function
2002 Standout
Saccadic Eye Movements of Dyslexic and Normal Reading Children
1994
Common Carotid Intima-Media Thickness and Risk of Stroke and Myocardial Infarction
1997 Standout
Mixed brain pathologies account for most dementia cases in community-dwelling older persons
2007 Standout
Elderly Patients, Caregivers, and Physicians: Theory and Research on Health Care Triads
1994
Works of J. Thomas Hutton being referenced
On the Problems of Speech Compensation and Fluctuating Intellectual Performance
1977
Levodopa Improves Spatial Contrast Sensitivity in Parkinson's Disease
1993
Multicenter, placebo-controlled trial of cabergoline taken once daily in the treatment of Parkinson's disease
1996
Treatment of Chronic Parkinson's Disease With Controlled-Release Carbidopa/Levodopa
1988
A Randomized, Double-blind, Placebo-Controlled Trial of Subcutaneously Injected Apomorphine for Parkinsonian Off-State Events
2001
Multicenter controlled study of Sinemet CR vs Sinemet (25/100) in advanced Parkinson's disease.
1989
Eye tracking dysfunction in Alzheimer‐type dementia
1984
Lateral saccadic latencies and handedness
1986
Senile dementia of the Alzheimer type
1985
Role of the senile plaque in neuropeptide deficits of Alzheimer's disease
1985
Vision in Parkinson's disease.
2001
Atrial Myxoma as a Cause of Progressive Dementia
1981
Visual information processing and dementia
1987
Oculomotor Programming Disturbances in the Dementia Syndrome
1979
Immediate-release and controlled-release carbidopa/levodopa in PD
1999
Computerized Tomography in the Diagnosis of Central and Extrapontine Myelinolysis
1981
Controlled study of the antiparkinsonian activity and tolerability of cabergoline
1993
Families of Alzheimer's Victims
1986
Long-acting carbidopa-levodopa in the management of moderate and advanced Parkinson's disease.
1992
Postural finger tremor exhibited by Parkinson patients and age‐matched subjects
1995
Head injury as a risk factor for Alzheimer's disease
1985